GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (CHIX:1SXPd) » Definitions » Asset Impairment Charge

Schott Pharma AG KGaA (CHIX:1SXPD) Asset Impairment Charge : €0.0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Schott Pharma AG KGaA Asset Impairment Charge?

Schott Pharma AG KGaA's Asset Impairment Charge for the three months ended in Jun. 2024 was €0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 was €0.0 Mil.

Schott Pharma AG KGaA Asset Impairment Charge Historical Data

The historical data trend for Schott Pharma AG KGaA's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Asset Impairment Charge Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23
Asset Impairment Charge
- - - -

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Schott Pharma AG KGaA Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Schott Pharma AG KGaA Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Schott Pharma AG KGaA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (CHIX:1SXPd) » Definitions » Asset Impairment Charge
Comparable Companies
Traded in Other Exchanges
1SXP:Germany 1SXP:Austria
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Website
https://www.schott-pharma.com
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines